翻译生物科学的一段英文

2024-12-04 17:56:41
推荐回答(5个)
回答1:

the contribution of bone marrow-derived circulating endothelial progentior cells to tumor angiogenesis has been controversial,primarily because of their low numbers in blood vessels of untreated tumors.

由于骨髓来源的循环内皮祖细胞在未治疗的肿瘤血管中含量很少,因此它在肿瘤血管生成的作用一直存在着争议。

we show an acute mobilization of CEPs.which home to the viable tumor rim that characteristically remains after such therapy.disruption of this CEP spilke by antiangiogenic drugs or by genetic manipulation resulted in marked reduction in tumor rim size and blood flow as well as enhanced VDA antitumor activity .

我们研究观察到CEP发生了急性动员,CEP来源于可存活肿瘤的边缘,即使在采用抗血管生成药物或者基因调控手段干扰CEP spike治疗后,这一特点依然存在。治疗显著减小了肿瘤体积和血流量,同时提高了VPA抗肿瘤活性。

these findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic drugs.
这些结论也为VDA与其他抗血管生成药物联合疗法的疗效升高提供了理论上的依据。

我水平差,只能翻译成这样,希望能有高手出现,好学习学习

回答2:

http://www.sciencemag.org/cgi/content/abstract/313/5794/1785

这样的材料翻译起来不轻松 很费力的

治疗中出现的acute recruitment of circulating
内皮前体细胞 to tumors
the contribution of 基于骨髓的circulating 内皮前体细胞 to 肿瘤血管生成 has been 有争议,主要因为在未经治疗的肿瘤血管中含量低.we show an acute mobilization of CEPs.which home to the viable tumor rim that characteristically remains after such therapy.disruption of this CEP spilke by 抗血管生成药物 or by genetic manipulation resulted in marked reduction in tumor rim size and blood flow as well as enhanced VDA 抗肿瘤活性.these findings also provide a 机械论基本原理for the enhanced 功效 of VDAs when combined with 抗血管生成药物 .

回答3:

the contribution of bone marrow-derived circulating endothelial progentior cells to tumor angiogenesis has been controversial,primarily because of their low numbers in blood vessels of untreated tumors.

由于骨髓来源的循环内皮祖细胞在未治疗的肿瘤血管中含量很少,因此它在肿瘤血管生成的作用一直存在着争议。

we show an acute mobilization of CEPs.which home to the viable tumor rim that characteristically remains after such therapy.disruption of this CEP spilke by antiangiogenic drugs or by genetic manipulation resulted in marked reduction in tumor rim size and blood flow as well as enhanced VDA antitumor activity .

我们研究观察到CEP发生了急性动员,CEP来源于可存活肿瘤的边缘,即使在采用抗血管生成药物或者基因调控手段干扰CEP spike治疗后,这一特点依然存在。治疗显著减小了肿瘤体积和血流量,同时提高了VPA抗肿瘤活性。

these findings also provide a mechanistic rationale for the enhanced efficacy of VDAs when combined with antiangiogenic dr效升高提供了理论上的依据。

我水平差,只能翻译成这样,希望能有高手出现

回答4:

文章在哪?我晕!!

回答5:

建议到http://www.83bio-lzu.cn求助,那里都是专家.